A Bioluminescent Assay for Quantification of Cellular Glycogen Levels

Donna Leippe,Rebeca Choy,Gediminis Vidugiris,Hanne Merritt,Kevin T Mellem,David T Beattie,Julie C Ullman,Jolanta Vidugiriene

DOI: https://doi.org/10.1101/2024.05.20.595028

2024-05-21

Abstract:Glycogen is a large polymer of glucose that functions as an important means of storing energy and maintaining glucose homeostasis. Glycogen synthesis and degradation pathways are highly regulated and their dysregulation can contribute to disease. Glycogen storage diseases are a set of disorders that arise from improper glycogen metabolism. Glycogen storage disease II, known as Pompe disease, is caused by a genetic mutation that leads to increased glycogen storage in cells and tissues, resulting in progressive muscle atrophy and respiratory decline for patients. One approach for treating Pompe disease is to reduce glycogen levels by interfering with the glycogen synthesis pathway through glycogen synthase inhibitors. To facilitate the study of glycogen synthase inhibitors in biological samples, such as cultured cells, a high-throughput approach for measuring cellular glycogen was developed. A bioluminescent glycogen detection assay was automated and used to measure glycogen content in cells grown in 384-well plates. The assay successfully quantified reduced glycogen stores in cells treated with a series of glycogen synthase 1 inhibitors, verifying inhibitor activity in biological systems and validating the utility of the assay for glycogen metabolism studies.

Biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop a high - throughput method to measure intracellular glycogen levels in order to support the screening and characterization of small - molecule modulators of glycogen synthase inhibitors. Specifically, the researchers are concerned with the accumulation and breakdown of glycogen in cells, especially its role in diseases such as Pompe Disease. Pompe Disease is a genetic disease in which glycogen accumulates excessively in cells and tissues due to mutations in the gene for acid α - glucosidase (GAA), which leads to progressive muscle atrophy and decline in respiratory function in patients. Reducing glycogen levels by interfering with glycogen synthase 1 (GYS1) in the glycogen synthesis pathway is considered a method for treating Pompe Disease.

To achieve this goal, the researchers developed a glycogen detection method based on bioluminescence technology, which can automatically measure the glycogen content in cells on 384 - well plates. This method not only improves the detection sensitivity and dynamic range, but also reduces the background signal, making it particularly suitable for high - throughput screening experiments. Through this method, the researchers verified the activities of multiple glycogen synthase 1 inhibitors, demonstrated the effectiveness of these inhibitors in biological systems, and verified the practicality of this detection method in studying glycogen metabolism.